In 1933, a small company in Osaka began making X-ray timers for hospitals. Over the next nine decades it went on to build Japan's first automated ticket gates, pioneer home blood pressure monitors, and help wire the infrastructure of modern society. Now Omron is selling the very business that started it all, to an American private equity giant, at an enterprise value of ¥81 billion ($540 million). Here is what happened and why it matters.

Omron Lets Go of Its 93-Year-Old Founding Business

On March 30, 2026, Omron Corporation, one of Japan's most iconic electronics companies, announced it would sell its Device & Module Solutions Business (DMB), the company's founding electronic components division, to The Carlyle Group, one of the world's largest private equity firms. The deal values the business at approximately ¥81 billion ($540 million).

For context, this isn't just any division being divested. Omron traces its origins to 1933, when founder Kazuma Tateishi established Tateishi Electric Manufacturing in Osaka. The company's first product was an X-ray photography timer for medical facilities. From there, it expanded into protective relays for power companies, which evolved into a full-scale electronic components business, relays, switches, sensors, and connectors that would become the technological backbone behind Japan's pioneering automated ticket gate systems and ATMs.

In Japanese business culture, a company's founding business, or "sogyo", carries almost sacred significance, similar to a family heirloom. Selling it is akin to selling part of the company's soul.

Why Sell the Crown Jewels?

Start with the numbers. For the year to March 2025, DMB posted revenue of ¥105.4 billion but operating profit of just ¥300 million, down 90.3% year on year. Roughly 70% of its sales come from overseas, and the profit had all but evaporated. The ¥81 billion enterprise value works out to about 0.77 times revenue.

Behind that lies a fundamental shift in the electronic components market.

The rapid expansion of electric vehicles (EVs) has created booming demand for high-capacity relays, seemingly a golden opportunity for Omron. However, Chinese manufacturers and other new entrants have flooded the market, triggering intense price competition. Omron recognized that capturing these opportunities would require investment "faster and larger than initially anticipated."

On September 19, 2025, Omron disclosed that it was studying a spin-off of the DMB division, targeting April 2026. By its own account, the spin-off solved for speed but not for scale: "in the current business environment, we recognized anew that investment faster and larger than anticipated is required, and concluded that transferring DMB to Carlyle is optimal."

This also accelerates Omron's medium-term roadmap, "SF 2nd Stage," covering fiscal 2026 through 2030. The company will concentrate resources on 13 priority businesses centered on Industrial Automation (IA), raising the share of development spending going to those businesses from roughly 40% today to about 60% by fiscal 2030, and adding more than 1,000 front-line and development staff.

How the Deal Works

The transaction unfolds in stages. On July 1, 2026, the DMB operations transfer to Omron Device, the Kyoto-based subsidiary that has run the components business since 2007, through an absorption-type corporate split. The entity is then renamed "Aratas," a name built on the Japanese word for "new."

On October 1, 2026, all shares of Aratas transfer to a special purpose company established by Carlyle. The detail worth noting: Omron will then re-invest for a 5% stake in that SPC. This is not a clean break. Sales partnerships stay in place, and Omron stays close enough to support the transition.

Who Is Carlyle?

The Carlyle Group, headquartered in Washington, D.C., manages approximately $441 billion in assets as of late 2024. The firm opened its Tokyo office in 2000, making it one of the first global PE firms to establish a dedicated presence in Japan.

Carlyle's Japan buyout platform has invested over ¥1 trillion across more than 41 private equity deals over 25 years. Its fifth Japan-focused fund, closed in May 2024 at ¥430 billion ($2.8 billion), was the largest buyout fund ever dedicated exclusively to the Japanese market. Recent Japanese deals include KFC Holdings Japan, software company Kaonavi, and specialty wire manufacturer TOTOKU.

The firm's Japan strategy centers on mid-market, domestically oriented companies, particularly succession deals and corporate carve-outs, which are increasingly common as Japanese conglomerates streamline their portfolios.

A Pattern of Strategic Pruning

This isn't Omron's first time making such a bold move. In 2019, the company sold its automotive electronics subsidiary to Nidec (then Nihon Densan) for approximately ¥100 billion ($670 million). Then-CEO Yoshihito Yamada called it "an agonizing decision" but explained that the automotive industry's once-in-a-century transformation required investment levels beyond Omron's capacity.

That sale generated ¥51.4 billion in gains and freed up resources for factory automation and healthcare, Omron's two strongest growth areas. The playbook is the same this time: if a business needs investment that exceeds your capacity, let someone else run with it and focus where you can win.

This approach reflects the Japanese management concept of "sentaku to shuchu", literally "selection and concentration", a strategy of deliberately choosing which battles to fight and pouring everything into them.

Japan's Electronics Industry Is Reshuffling

Omron's decision fits a broader pattern reshaping Japan's electronics sector. Japan was once the undisputed king of electronic components, but commoditization in standard parts, driven by Chinese, Korean, and Taiwanese competitors, has eroded margins for many Japanese manufacturers.

At the same time, growth areas like EVs, artificial intelligence, and advanced robotics demand massive capital investment in next-generation technology. For mid-sized Japanese component makers, fighting on every front is no longer viable. The result is an accelerating wave of divestitures, carve-outs, and strategic partnerships.

What's particularly notable is the cultural shift this represents. Traditional Japanese corporate culture viewed selling a founding business as nearly unthinkable, a betrayal of the company's heritage and the founder's legacy. The growing acceptance of such moves signals that Japanese businesses are increasingly prioritizing shareholder value and capital efficiency through metrics like ROIC (Return on Invested Capital) over sentimental attachment to legacy operations.

What Omron Looks Like After the Sale

Post-divestiture, Omron will concentrate on three strategic pillars.

First, Industrial Automation (IA). As a leading provider of factory automation solutions, sensors, controllers, and collaborative robots, Omron sees enormous growth potential in the global smart factory revolution.

Second, Healthcare. Omron holds the world's top market share in home electronic blood pressure monitors and is expanding into remote health monitoring, wearable medical devices, and digital health platforms.

Third, Social Systems and Data Solutions. Building on its legacy in automated ticket gates and urban infrastructure, Omron is developing data-driven services that leverage the vast information gathered across its business portfolio.

The Emotional Weight of Letting Go

In Japan, there's a concept called "mottainai", a deep sense of regret over waste, of letting something valuable go unused. When a company sells its founding business, there's inevitably a feeling of mottainai among employees, investors, and the public alike.

But Omron appears to be reframing the narrative: rather than letting the electronic components business struggle within a conglomerate that can't provide the investment it needs, transferring it to Carlyle, a firm with deep manufacturing expertise and the capital to invest aggressively, gives the business its best chance to thrive. The new name, "Aratas," meaning renewal, reinforces this message.

In your country, how do people react when a long-established company sells its founding business? Is it seen as a smart strategic move, or does it feel like something important is being lost? We'd love to hear your perspective.

References